Operable breast cancer patients may experience late recurrences because of reactivation of dormant tumor cells within the bone marrow (BM). Identification of patients who would benefit from extended therapy is therefore needed. | Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients